Advertisement
Product › Details
Lantus®
Next higher product group | insulin glargine (INN) | |
Status | 2000-06-06 registration start | |
Organisation | Hoechst Marion Roussel Deutschland GmbH | |
Group | Sanofi (Group) [since May 2011] | |
Record changed: 2023-07-10 |
Advertisement
More documents for insulin
- [1] Sanofi S.A.. (6/9/19). "Press Release: Soliqua Phase 3 Results Significantly Lowered Blood Sugar Levels Compared to GLP-1 Receptor Agonist Treatments". Paris....
- [2] Adocia S.A.. (10/11/18). "Press Release: Adocia Informs about a Civil Action Filed by Eli Lilly". Lyon....
- [3] Scenic Biotech B.V.. (6/25/18). "Press Release: Scenic Appoints Ulrich Grau as Chairman of the Board"....
- [4] Sanofi S.A.. (4/27/18). "Press Release: First-quarter 2018 Business EPS up 1.4% at CER". Paris....
- [5] Sanofi S.A.. (1/4/17). "Press Release: Sanofi Announces Soliqua 100/33 Now Available in the U.S.". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top